E
Epic Sciences
Diagnostics company that's improving cancer management by providing real-time biopsy material to guide personalized medicine
About Epic Sciences
Epic Sciences is a biotechnology startup that operates in the cancer diagnostics market. The company offers a unique service known as Comprehensive Cancer Profiling. This service uses a multi-technology approach to analyze a single blood draw from a patient, providing valuable insights for clinicians and drug development professionals, particularly those focused on prostate and breast cancer.
The company's proprietary technology allows for the detection of circulating tumor cells (CTCs), cell-free tumor DNA (ctDNA), and immune cells in the blood. This information can help doctors understand the genetic makeup and behavior of cancer cells, which can guide treatment decisions. This is especially useful for patients with metastatic castration-resistant prostate cancer (mCRPC), a type of cancer that is difficult to treat.
Epic Sciences' AR-V7 test is the first of its kind to be reimbursed by Medicare. This test requires only a simple blood draw and can help patients and their doctors choose the most effective therapies.
In addition to serving patients and clinicians, Epic Sciences also partners with pharmaceutical and clinical investigation teams. The company's unbiased approach to cancer research helps these teams develop new drugs and understand how cancer grows and evolves.
Epic Sciences' business model is based on providing these diagnostic services to patients, clinicians, and pharmaceutical companies. The company makes money by charging for these services and through partnerships with other organizations in the healthcare sector.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- University City, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 66.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Predictive Analytics, Biotechnology, Oncology, Biopsy, Precision Medicine, Non-Invasive medical devices and treatments, Immersive Technologies
- Technology
- Deep Tech, Augmented Reality
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES GOther financing | Apr 2023 | $24M | $260M | Arsenal Capital Partners · LabCorp · Domain Associates · Blue Ox Healthcare Partners | ↗ |
| SERIES FOther financing | Jun 2022 | $42M | $260M | Arsenal Capital Partners · LabCorp · Deerfield · Blue Ox Healthcare Partners | ↗ |
Growth signals
Latest recorded traffic for Epic Sciences is 310 monthly website visits, down 74.2% over the last three months. Epic Sciences's team declined 9.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Venrock
Domain Associates
Roche Venture Fund
Series B and later15 investors entered at this stage
Arcus Ventures
RMI Partners
Silicon Valley Bank- PIPagoda Investment
- VIViventures
Genomic Health
Sabby Capital- HCHermed Capital
- BPBlue Ox Healthcare Partners
- VAVarian
- SMSabby Management
Alexandria Venture Investments
Arsenal Capital Partners
LabCorp
Deerfield
Other known investors1 additional known investor
Scripps Translational Science Institute
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Epic Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Epic Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.